secwatch.observer — SEC 8-K summary
======================================

Issuer:     FENNEC PHARMACEUTICALS INC. (FENC)
CIK:        0001211583
Form:       8-K
Filed at:   2025-11-18T23:59:59+00:00
Accession:  0001104659-25-113646
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Fennec raises $5.025M in Canadian private placement, redeems $21.7M Petrichor notes
--------------------------------------------------------------------------------

- Issued 670,000 common shares at US$7.50 per share for gross proceeds of $5,025,000 from existing institutional shareholders in Canada (excl. Quebec).
- Offering closed November 18, 2025; shares registered under S-3 shelf and exempt from Canadian hold period.
- Net proceeds plus other funds to repurchase and redeem Petrichor convertible notes for ~$21.73 million, due Nov 19, 2025.
- Non-brokered, no placement agent; TSX approval obtained under Section 602.1 for interlisted issuer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1211583/000110465925113646/0001104659-25-113646-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1211583/000110465925113646/tm2531509d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-113646

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer